Format

Send to

Choose Destination
Korean J Urol. 2015 May;56(5):357-64. doi: 10.4111/kju.2015.56.5.357. Epub 2015 Apr 28.

Does skip metastasis or other lymph node parameters have additional effects on survival of patients undergoing radical cystectomy for bladder cancer?

Author information

1
Department of Urology, Private Akay Hospital, Ankara, Turkey.
2
Department of Urology, Faculty of Medicine, Ankara University, Ankara, Turkey.
3
Department of Urology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
4
Department of Urology, Eskişehir Osmangazi University Medical Faculty, Eskişehir, Turkey.
5
Department of Urology, Ege University Medical Faculty, Izmir, Turkey.
6
Department of Biostatistics, Faculty of Medicine, Ankara University, Ankara, Turkey.
7
Department of Urology, Marmara University School of Medicine, Istanbul, Turkey.
8
Department of Urology, Karaelmas University, School of Medicine, Zonguldak, Turkey.

Abstract

PURPOSE:

To investigate the effects of lymph node metastasis, skip metastasis, and other factors related to lymph node status on survival in patients who underwent radical cystectomy (RC) and extended lymph node dissection (eLND).

MATERIALS AND METHODS:

RC and eLND were performed in 85 patients with a diagnosis of bladder cancer. Disease-free survival (DFS) and overall survival (OS) were determined by using a Cox proportional hazards model that included the number of excised lymph nodes, the presence of pathological lymph node metastasis, the anatomical level of positive nodes, the number of positive lymph nodes, lymph node density, and the presence of skip metastasis.

RESULTS:

The mean number of lymph nodes removed per patient was 29.4±9.3. Lymph node positivity was detected in 85 patients (34.1%). The mean follow-up duration was 44.9±27.4 months (2-93 months). Five-year estimated OS and DFS for the 85 patients were 62.6% and 57%, respectively. Three of 29 lymph node-positive patients (10.3%) had skip metastasis. Only lymph node positivity had a significant effect on 5-year OS and DFS (p<0.001). No difference in OS and DFS was found between the three patients with skip metastasis and other lymph node-positive patients. Other factors related to lymph node status had no significant effect on 5-year OS and DFS.

CONCLUSIONS:

No factors related to lymph node status predict DFS and OS, except for lymph node positivity. OS and DFS were comparable between patients with skip metastasis and other lymph node-positive patients.

KEYWORDS:

Lymph node excision; Treatment outcome; Urinary bladder neoplasms

PMID:
25964836
PMCID:
PMC4426507
DOI:
10.4111/kju.2015.56.5.357
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Korean Urological Association Icon for PubMed Central
Loading ...
Support Center